Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
West Wits Mining adds 428,000 ounces to South African gold bounty

2018-07-16 proactiveinvestors.com.au
West Wits Mining Limited (ASX:WWI) has added another 428,000 ounces to its gold bounty at the Witwatersrand Basin Project (WBP) in the world’s largest goldfield in South Africa.
HMY WWI HGMCF

0
West Wits Mining on its way to becoming a ‘full scale production company’

2018-05-21 proactiveinvestors.com.au
West Wits Mining Limited’s (ASX:WWI) chairman Michael Quinert tells Proactive Investors a mining rights application for the Witwatersrand Basin Project (WBP) has been accepted for processing by the South African mining regulator.
WWI

0
West Wits Mining transforming into a junior gold miner in South Africa

2018-05-15 proactiveinvestors.com.au
West Wits Mining Limited’s (ASX:WWI) mining rights application for the Witwatersrand Basin Project (WBP) has been accepted for processing by the South African mining regulator.
WWI

0
West Wits Mining discovers visible gold in all samples from the Tambina Project

2018-05-02 proactiveinvestors.com.au
West Wits Mining Limited’s (ASX:WWI) second site visit to the Tambina Project in the Pilbara region has returned visible gold nuggets and in-pan concentrates.
WWI

2
West Wits Mining is an emerging conglomerate-hosted gold producer

2018-04-12 proactiveinvestors.com.au
West Wits Mining Ltd (ASX:WWI) is targeting conglomerate-hosted gold with a focus on two regions, the Witwatersrand Basin of South Africa and Pilbara region of Western Australia.
WWI NSRPF NVO

0
West Wits Mining submits two mining permits, on track for gold production increase

2018-04-12 proactiveinvestors.com.au
West Wits Mining Ltd (ASX:WWI) has submitted two mining permit applications to enable a substantial increase in gold production from its Witwatersrand Basin Project (WBP) in South Africa.
WWI

0
West Wits Mining chairman increases shareholding ahead of Tambina gold exploration

2018-04-05 proactiveinvestors.com.au
West Wits Mining Limited’s (ASX:WWI) executive chairman Michael Quinert has increased his shareholding in the company with an on-market purchase of about 230,000 shares.
WWI

0
West Wits Mining director doubles his stake as Tambina activity ramps up

2018-03-28 proactiveinvestors.com.au
West Wits Mining Limited’s (ASX:WWI) exploration director Andrew Tunks has nearly doubled his stake in the company with the purchase of 475,000 shares.
WWI

0
West Wits Mining eyes conglomerate hosted gold targets in the Pilbara

2018-03-28 proactiveinvestors.com.au
West Wits Mining Limited (ASX:WWI) is aiming to identify conglomerate-hosted gold targets at its Tambina project in Western Australia, to test whether small-scale mining operations can recommence.
WWI

0
West Wits Mining adds expert exploration consultant to board

2018-03-13 proactiveinvestors.com.au
West Wits Mining Ltd (ASX:WWI) has promoted its expert exploration consultant, Dr Andrew Tunks, to sit on the company’s board as an executive director. Dr Tunks will be in charge of the group’s exploration activities in the Witwatersrand Basin of South Africa and Pilbara region of Western Australia.
WWI

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:WWI / WEST WITS MINING LIMITED on message board site Silicon Investor.

TWWI Thrive World Wide Inc. WWW Internet Fund (WWIFX) - doubled in first 4 months!